home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
  HUM-MOLGEN -> Events -> Meetings and Conferences


  RNA in Drug Development  
  July 17, 2003


  The Knowledge Foundation, Inc., San Diego, CA
11/10 - 11/11/2003

Detailed agenda available at website.

This internationally recognized symposium will provide you with a competitive insight into the current state of RNA research and development by bringing together leading researchers focusing on areas such as: RNA intereference,
ribozymes, aptamers, antisense technology, alternative splicing and targets for antibiotic therapies.

Some topics addressed by our distinguished faculty:

• Photoaptamers
• Biostable aptamers
• Alternative mRNA splicing
• Splicing by PNA
• Creating a comprehensive siRNA based library
• Chemically modified siRNA
• Identifying therapeutic targets using Inverse Genomics®
• Strategies for rational ligand discovery
• Microarrays to identify carbohydrate- RNA interactions
• Antisense mechanisms in drug development

Workshop on RNA Delivery: November 11, 2003

RNA has demonstrated great potential as a therapetic tool. However, efficient delivery of RNA to target remains a major challenge. This workshop focuses on efficient delivery of siRNA to retinal cells, Antisense delivery, Lenti Virus Vector mediated expression of RNAi, ssDNA expression systems and delivery of siRNA in Vivo.

Organized by: The Knowledge Foundation, Inc.
Invited Speakers: F. Bennett, Isis Pharmaceuticals, Inc.
Y. Chen, CytoGenix, Inc.
S. Cload, Archemix Corp.
P. Eder, Message Pharmaceuticals, Inc.
T. Giordano, Sliceomix, Inc.
T. Hermann, Anadys Pharmaceuticals, Inc.
H. Herweijer, Mirus Corp.
P. Iversen, Avi Biopharma
S. Kjaerulff, Santaris A/S
M. Manoharan, Alnylam Pharmaceuticals
K. McGowan, ExonHit Therapeutics
C. Novina, MIT
S. Reich, Acuity Pharmaceuticals, Inc.
K. Rhoades, Immusol, Inc.
R. Roberts, California Institute of Technology
S. Scaringe, Dharmacon, Inc.
P. Seeberger, Swiss Federal Institute of Technology
D. Smith, Somalogic, Inc.
S. Stewart, Whitehead Institute
B. Sullenger, Duke University Medical Center
M. Tolentino, University of Pennsylvania
D. Tornus, Noxxon Pharma AG
N. Usman, Sirna Therapeutics
Deadline for Abstracts: none
Registration: online registration available or, via phone: 617-232 7400
E-mail: meder@knowledgefoundation.com
  Posted by:   Margit Eder  
home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap

Generated by meetings and positions 5.0 by Kai Garlipp
WWW: Kai Garlipp, Frank S. Zollmann.
7.0 © 1995- HUM-MOLGEN. All rights reserved. Liability, Copyright and Imprint.